Vericel Corporation
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$6.8M
Doctors Paid
5,499
Transactions
14,799
2024 Total
$1.3M
Payment Breakdown by Category
Research$2.2M (32.5%)
Consulting$1.5M (22.6%)
Food & Beverage$490,857 (7.2%)
Travel$328,408 (4.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.2M | 359 | 32.5% |
| Consulting Fee | $1.5M | 633 | 22.6% |
| Honoraria | $1.2M | 504 | 18.3% |
| Compensation for serving as faculty or as a speaker for a medical education program | $553,600 | 222 | 8.1% |
| Food and Beverage | $490,857 | 11,548 | 7.2% |
| Travel and Lodging | $328,408 | 1,040 | 4.8% |
| Grant | $228,748 | 24 | 3.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $113,816 | 59 | 1.7% |
| Charitable Contribution | $79,723 | 32 | 1.2% |
| Education | $17,185 | 351 | 0.3% |
| Entertainment | $2,155 | 27 | 0.0% |
Payments by Type
General
$4.6M
14,440 transactions
Research
$2.2M
359 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered Via Transendocardial Catheter-based Injections to Subjects With Heart Failure Due to Ischemic Dilated Cardiomyopathy (IDCM) (ixCELL DCM) | $1.0M | 5 | 114 |
| A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee (PEAK) | $409,961 | 0 | 29 |
| A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee PEAK | $314,763 | 0 | 60 |
| PEdiatric Autologous cultured chondrocytes treatment of cartilage defects in the Knee: A Study of MACI in Patients Aged 10 to ?17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee | $150,537 | 0 | 35 |
| Retrospective analysis of MACI clinical outcomes | $94,662 | 0 | 2 |
| MACI Multicenter Clinical Outcomes Registry | $50,870 | 2 | 21 |
| A Study of MACI in Patients Aged 10 to <17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee (PEAK) | $44,983 | 18 | 86 |
| Return to Work and Sport after MACI Treatment in the Knee | $29,992 | 0 | 1 |
| Epicel Registry | $23,035 | 0 | 4 |
| An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered Via Transendocardial catheter-based Injections to Subjects With Heart Failure Due to Ischemic Dilated Cardiomyopathy (IDCM) (ixCELL DCM) | $11,018 | 0 | 1 |
| MACI Surgical Technique Video | $10,600 | 0 | 1 |
| Epicel Regsitry Study | $10,100 | 0 | 3 |
| Application and Management of CEAs on Posterior Burns-A Five Year Multicenter, Retrospective Review of Outcomes | $8,500 | 0 | 1 |
| Study of Knee Joint Cartilage Repair Using Autologous vs. Allogeneic MACI in a Rabbit Model | $4,741 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| David Flanigan, Md, MD | Sports Medicine | Columbus, OH | $301,078 | $0 |
| Dr. Deryk Jones, Md, MD | Sports Medicine | San Carlos, CA | $242,105 | $0 |
| Dr. Wayne Gersoff, M.d, M.D | Orthopaedic Surgery | Denver, CO | $175,244 | $0 |
| Dr. Eric Strauss, M.d, M.D | Orthopaedic Surgery | New York, NY | $138,950 | $0 |
| Geoffrey Van Thiel, Md, MD | Sports Medicine | Rockford, IL | $138,566 | $0 |
| Dr. Matthew Tao, Md, MD | Sports Medicine | New York, NY | $132,669 | $0 |
| Dr. David Recker, M.d, M.D | Internal Medicine | Libertyville, IL | $129,516 | $0 |
| Tom Minas, Md, MD | Orthopaedic Surgery | West Palm Beach, FL | $125,579 | $0 |
| Dr. Brian Waterman, Md, MD | Orthopaedic Surgery | Winston Salem, NC | $119,321 | $0 |
| Dr. Cassandra Lee, Md, MD | Orthopaedic Surgery | Sacramento, CA | $109,799 | $0 |
| Seth Sherman, Md, MD | Orthopaedic Surgery | Stanford, CA | $101,924 | $0 |
| Michael Banffy, Md, MD | Sports Medicine | Los Angeles, CA | $100,722 | $0 |
| Dr. James Carey, Md, MD | Orthopaedic Surgery | Philadelphia, PA | $100,341 | $0 |
| Dr. Grant Garcia, Md, MD | Sports Medicine | Seattle, WA | $99,381 | $0 |
| Dr. Michael Kuhn, Md, MD | Orthopaedic Surgery | Middletown, CT | $86,042 | $0 |
| Kai Mithoefer, M.d, M.D | Orthopaedic Surgery | Ded Ham, MA | $64,442 | $0 |
| Dr. Steven Kahn | Surgery | Charleston, SC | $57,884 | $0 |
| Dr. Scott Gillogly, M.d, M.D | Orthopaedic Surgery | Cartersville, GA | $57,691 | $0 |
| Dr. Christian Lattermann, Md, MD | Orthopaedic Surgery | Boston, MA | $57,226 | $0 |
| Dr. Joseph Czarnecki, M.d, M.D | Sports Medicine | Woburn, MA | $52,167 | $0 |
| Dr. Gregory Purnell, Md, MD | Orthopaedic Surgery | Morgantown, WV | $47,455 | $0 |
| Ronak Patel, Md, MD | Sports Medicine | Hinsdale, IL | $39,769 | $0 |
| Alison Toth, Md, MD | Orthopaedic Surgery | Durham, NC | $38,711 | $0 |
| Joseph Berman, M.d, M.D | Orthopaedic Surgery | Arlington, TX | $38,106 | $0 |
| Dr. Kenneth Akizuki, Md, MD | Orthopaedic Surgery | San Francisco, CA | $36,103 | $0 |
Ad
Top Products
- MACI $4.6M
- ixmyelocel-T $1.1M
Associated Products (6)
- MACI $4.6M
- ixmyelocel-T $1.1M
- MACI _ PEAK Study $409,931
- EPICEL (CULTURED EPIDERMAL AUTOGRAFTS) $171,138
- Nexobrid $151,856
- Epicel $76,040
Payment Categories
- Food & Beverage $490,857
- Consulting $1.5M
- Travel & Lodging $328,408
- Research $2.2M
About Vericel Corporation
Vericel Corporation has made $6.8M in payments to 5,499 healthcare providers, recorded across 14,799 transactions in the CMS Open Payments database. In 2024, the company paid $1.3M. The top product by payment volume is MACI ($4.6M).
Payments were distributed across 104 medical specialties. The top specialty by payment amount is Orthopaedic Surgery ($2.1M to 2,429 doctors).
Payment categories include: Food & Beverage ($490,857), Consulting ($1.5M), Research ($2.2M), Travel & Lodging ($328,408).
Vericel Corporation is associated with 6 products in the CMS Open Payments database, including MACI, ixmyelocel-T, and MACI _ PEAK Study.